ArticleClinical and experimental medicine2026
Exploratory study of PD-1 inhibitors with or without ruxolitinib for the treatment of adult EBV-associated hemophagocytic lymphohistiocytosis: a real-world data-based preliminary investigation.
Zhao Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.